LI XU, M.D.
Venture Partner
Li Xu, M.D., is a Venture Partner with Lilly Asia Ventures (LAV). Prior to joining LAV, Li was Vice President and Head of Oncology at Hengrui, and prior to that, Vice President of Global Strategy at Pfizer. Li’s previous experience also includes Merck and Immunomedics. Li is a trained surgical oncologist who completed fellowship training at the Memorial Sloan Kettering cancer center, and also holds an M.D. from Shandong Medical University and M.B.A. from Fairleigh Dickenson.
Company
Shanghai
Room2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Hong Kong
Unit 902-904, Two ChinaChem Central, 26 Des Voeux Road Central, Hong Kong
US
2730 Sand Hill Road, Suite 130, Menlo Park, CA